Transfusion-acquired HIV infection among immunocompromised hosts.
This survey suggests that HIV infection in immunocompromised hosts is characterized by a high attack rate, short incubation time to clinical sequelae, and WB and RIP seropositivity which may precede evidence of antibodies by ELISA by weeks or months. The functional properties of patients' serum antibodies, such as neutralizing activity against HIV in vitro, may correlate with clinical course.
D000163:Acquired Immunodeficiency Syndrome / Q000209:etiology / Q000276:immunology / Q000635:transmission*; D000914:Antibodies, Viral / Q000032:analysis; D015483:HIV Antibodies; D006801:Humans; D007108:Immune Tolerance; D009369:Neoplasms / Q000150:complications / Q000276:immunology / Q000628:therapy; D013997:Time Factors; D065227:Transfusion Reaction
D000914:Antibodies, Viral; D015483:HIV Antibodies